Genome & Company (KOSDAQ:314130)
2,890.00
-15.00 (-0.52%)
Last updated: Nov 19, 2025, 2:31 PM KST
-0.52% (1Y)
| Market Cap | 88.90B |
| Revenue (ttm) | 24.02B |
| Net Income (ttm) | -27.08B |
| Shares Out | 31.09M |
| EPS (ttm) | -875.42 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 121,550 |
| Average Volume | 687,130 |
| Open | 2,905.00 |
| Previous Close | 2,905.00 |
| Day's Range | 2,810.00 - 2,925.00 |
| 52-Week Range | 2,170.00 - 3,495.00 |
| Beta | 0.85 |
| RSI | 46.94 |
| Earnings Date | Nov 14, 2025 |